Shanghai, China, November 9, 2024 — Aker BioMarine, a global leader in krill-based nutrition, continues to deepen its footprint in China, showcasing its commitment to the market with its sixth consecutive appearance at the China International Import Expo (CIIE).
This year, the company signed nearly 30 strategic agreements with partners across the country, further advancing its expansion strategy.
The new agreements highlight Aker BioMarine’s focus on strengthening collaborations with Chinese partners to develop krill-related projects. These efforts align with China’s increasing demand for high-quality nutritional products, supporting the country’s “Healthy China 2030” initiative aimed at enhancing public health and wellness.
“Our continued expansion in China reflects the immense potential we see in this market,” said Simon Seward, CEO of Human Health Ingredients at Aker BioMarine. “We remain dedicated to leveraging our expertise in sustainable marine resources to contribute to the health and wellness of Chinese consumers.”
Innovative Antarctic Krill Products Highlighted at CIIE
At the Expo, Aker BioMarine showcased its flagship Superba Krill® products, along with a range of krill oil derivatives, including capsules, powders, gummies, and poppers designed to meet diverse consumer needs. Additionally, the company introduced FloraMarine, an algal oil rich in DHA, making its first appearance in China.
“Our Superba Krill Oil is sustainably harvested from the pristine waters of Antarctica, making it rich in phospholipid-bound Omega-3s, choline, and astaxanthin. Backed by over 50 clinical studies, it offers proven benefits for heart health, joint flexibility, and anti-aging, offering a comprehensive package of health benefits, Seward said.”
Supporting China’s Health Goals
Since entering the Chinese market in 2011, Aker BioMarine has steadily expanded its presence and investment, recognizing the growing consumer interest in health and wellness. The bioavailability of nutrients in krill oil, thanks to its unique phospholipid structure, aligns with China's shift toward preventive health measures.
“China’s focus on health and sustainable development resonates deeply with our mission at Aker BioMarine,” said Thong Luu, General Manager China, Aker BioMarine. “Partnering with local companies allows us to not only grow our business but also drive positive change by delivering science-backed nutrition through environmentally sustainable practices.”
Looking Ahead: Enhancing Market Impact
With health and wellness becoming top priorities for consumers, Aker BioMarine is set to expand its offerings and collaborations in China. The company’s focus on innovation and sustainability will continue to drive its efforts to provide healthier, more sustainable nutritional solutions in the region.
About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.